Skip to main content
CSL Ltd. logo

CSL Ltd. — Investor Relations & Filings

Ticker · CSL ISIN · AU000000CSL8 LEI · 529900ECSECK5ZDQTE14 ASX Manufacturing
Open in API
Filings indexed 2,555 across all filing types
Latest filing 2010-11-04 Transaction in Own Shar…
Country AU Australia
Listing ASX CSL

About CSL Ltd.

https://www.csl.com/

CSL is a global biotechnology company that researches, develops, manufactures, and markets a diverse portfolio of medicines. The company operates through distinct business units. CSL Behring provides plasma-derived and recombinant biotherapies for patients with rare and serious diseases, including bleeding disorders, immunodeficiencies, and neurological disorders. CSL Seqirus is a leading provider of vaccines, with a focus on influenza prevention and public health. CSL Vifor specializes in therapies for iron deficiency and nephrology, addressing the full spectrum of kidney disease. Collectively, CSL delivers lifesaving and life-enhancing treatments to a global patient population.

Recent filings

Filing Released Lang Actions
Daily share buy-back notice - Appendix 3E 2 pages ?Kb
Transaction in Own Shares Classification · 100% confidence The document is titled 'Appendix 3E Daily share buy-back notice' and references ASX rules related to share buy-backs. It provides detailed information about the number of shares bought back, prices paid, and compliance statements. This is a report of the company's daily share repurchase activity, which fits the description of a 'Transaction in Own Shares' filing. The document length is 2642 characters, which is consistent with a notice rather than a full financial report. There is no indication that this is an announcement of a report publication or a regulatory filing unrelated to share transactions. Therefore, the appropriate classification is POS (Transaction in Own Shares).
2010-11-04 English
Change to Company Details ASIC Form 484 6 pages ?Kb
Regulatory Filings
2010-11-04 English
Daily share buy-back notice - Appendix 3E 2 pages ?Kb
Transaction in Own Shares Classification · 100% confidence The document is titled 'Appendix 3E Daily share buy-back notice' and contains detailed information about the company's on-market share buy-back activity, including number of shares bought back, prices paid, and compliance statements. It references ASX rules and is a formal notice to the exchange about share repurchase activity. The document length is short (2640 characters) and it is not a report or financial statement but a regulatory notice about share buy-back transactions. This matches the description of 'Transaction in Own Shares' filings, which report company buy-back or sale of its own shares. Therefore, the correct classification is POS (Transaction in Own Shares).
2010-11-03 English
Daily Share Buy-Back Notice 2 pages ?Kb
Regulatory Filings
2010-11-02 English
Daily Share Buy-Back Notice 2 pages ?Kb
Regulatory Filings
2010-11-01 English
Daily Share Buy-Back Notice 2 pages ?Kb
Regulatory Filings
2010-10-31 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.